Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model

Fig. 2

Relative expression of miR-542-5p in different clinicopathological groups of NSCLC patients. a, b, c and d: In NSCLC, different expression of miR-542-5p in relative groups are divided by TNM, vascular invasion, lymphatic metastasis and EGFR status; e, f, g and h: In LUAD, different expression of miR-542-5p in relative groups are divided by TNM, vascular invasion, lymphatic metastasis and EGFR status; i: In LUSC, different expression levels of miR-542-5p in relative groups are divided by EGFR status

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us